FDA advisers recommend Moderna COVID booster for seniors, others at high risk
By
Alicia Lasek
Oct 15, 2021
In a unanimous vote, advisers agreed that vulnerable Moderna vaccine recipients should be offered a third shot. A half dose will be effective and will help protect against side effects, the drugmaker says.
Wearers of medical masks and respirators have same infection rates in healthcare settings: study
By
Alicia Lasek
Jun 24, 2021
The risk of receiving a positive COVID-19 test result was the same among healthcare workers who wore either type of mask, investigators say. In contrast, their non-mask-wearing colleagues had significantly...
ICAA proposes post-pandemic wellness model for the active aging industry
By
Alicia Lasek
Apr 27, 2021
A new wellness model will help providers, clients and residents rise above the loss and fear experienced during the pandemic and reclaim their lives and businesses, according to the International Council...
U.S. labs predict COVID test delays, cite surge in demand
By
Alicia Lasek
Nov 16, 2020
Long-term care facilities soon may face longer waits for PCR test results as diagnostic laboratories reach or exceed testing capacity, lab reps say. The warning comes as U.S. COVID cases spike upward.
CDC: More nursing homes now can obtain, provide single-dose COVID vaccines
By
Alicia Lasek
Dec 20, 2022
Nursing homes that are not already enrolled as full providers in the CDC’s COVID-19 Vaccination Program now can apply to provide shots directly to residents and staff.
Fauci: Early data show omicron spreads quickly but with less severity than delta
By
Alicia Lasek
Dec 08, 2021
Omicron cases appear to have led to fewer hospitalizations and patients have been less likely to need oxygen, the White House’s infectious disease expert said Tuesday.
J&J vaccine effective against COVID Delta variant, drugmaker says
By
Alicia Lasek
Jul 06, 2021
Johnson & Johnson’s single-shot COVID-19 vaccine prompts a “strong neutralizing antibody response” that lasts at least eight months, the drugmaker has announced.
No severe reactions to COVID-19 vaccine so far in long-term care: early reports
By
Alicia Lasek
Jan 04, 2021
The initial onsite clinic experience was positive overall, despite some expected side effects, says industry advocate LeadingAge, whose affiliates represent 43 states.
COVID trial vaccines may be inadequate, some FDA advisors fear
By
Alicia Lasek
Oct 26, 2020
The current vaccine trials may be too focused on mild rather than severe disease, some advisors contend. But their arguments got pushback in a meeting streamed on the agency’s YouTube channel.
Time from infection to COVID symptoms shortens with each new variant, study finds
By
Alicia Lasek
Aug 24, 2022
The average incubation period of SARS-CoV-2 has gradually shortened, from 5 days to 3.4. Determining incubation periods can help to pinpoint effective patient isolation periods, investigators say.